Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to fight the most hard-to-treat cancers. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma...
Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to fight the most hard-to-treat cancers. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has designed a potent next-generation personalized immunization platform.

List your booth number for exhibitions, ask us